Display options
Cite
O'Brien TM, Hosseinzadeh S, Chen AF, et al. Establishing a recommended duration of blood glucose monitoring in nondiabetic patients following orthopaedic surgery. J Orthop Res. 2021;doi: 10.1002/jor.25202.
O'Brien, T. M., Hosseinzadeh, S., Chen, A. F., Verrier, K. I., Melnic, C. M., Humphrey, T. J., & Bedair, H. S. (2021). Establishing a recommended duration of blood glucose monitoring in nondiabetic patients following orthopaedic surgery. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, . https://doi.org/10.1002/jor.25202
O'Brien, Todd M, et al. "Establishing a recommended duration of blood glucose monitoring in nondiabetic patients following orthopaedic surgery." Journal of orthopaedic research : official publication of the Orthopaedic Research Society vol. (2021). doi: https://doi.org/10.1002/jor.25202
O'Brien TM, Hosseinzadeh S, Chen AF, Verrier KI, Melnic CM, Humphrey TJ, Bedair HS. Establishing a recommended duration of blood glucose monitoring in nondiabetic patients following orthopaedic surgery. J Orthop Res. 2021 Oct 21; doi: 10.1002/jor.25202. Epub 2021 Oct 21. PMID: 34674307.
Copy Download .nbib Format: NLM
Share it on

J Orthop Res. 2021 Oct 21; doi: 10.1002/jor.25202. Epub 2021 Oct 21.

Establishing a recommended duration of blood glucose monitoring in nondiabetic patients following orthopaedic surgery.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society

Todd M O'Brien, Shayan Hosseinzadeh, Antonia F Chen, Kimberly I Verrier, Christopher M Melnic, Tyler J Humphrey, Hany S Bedair

Affiliations

  1. Department of Orthopaedics, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
  2. Department of Orthopaedics, Brigham and Women's Hospital, Boston, Massachusetts, USA.

PMID: 34674307 DOI: 10.1002/jor.25202

Abstract

Previous studies have demonstrated that blood glucose (BG) levels should be monitored for at least 1 week after orthopaedic surgery in diabetic patients, but no study has determined how long nondiabetic patients should be monitored. As postoperative elevations in BG have deleterious effects, determining a duration for monitoring the BG of nondiabetic patients after major orthopaedic surgery is needed to detect hyperglycemic events, create comprehensive protocols for nondiabetic orthopaedic patients, and reduce adverse outcomes. A retrospective study was conducted including consecutive patients who underwent a major orthopaedic surgery at a community hospital. A BG level of 150 mg/dl was the cutoff used to define hyperglycemia according to our institutional guidelines. A χ

© 2021 Orthopaedic Research Society. Published by Wiley Periodicals LLC.

Keywords: blood glucose monitoring; care protocol; diabetes; inpatient; patient outcomes

References

  1. Evans CH, Lee J, Ruhlman MK. Optimal glucose management in the perioperative period. Surg Clin North Am. 2015;95:95-54. - PubMed
  2. Schricker T, Gougeon R, Eberhart L, et al. Type 2 diabetes mellitus and the catabolic response to surgery. Anesthesiology. 2005;102:320-326. - PubMed
  3. Lattermann R, Carli F, Wykes L, Schricker T. Perioperative glucose infusion and the catabolic response to surgery: the effect of epidural block. Anesth Analg. 2003;96:96-562. - PubMed
  4. Takesue Y, Tsuchida T. Strict glycemic control to prevent surgical site infections in gastroenterological surgery. Ann Gastroenterol Surg. 2017;1:1-59. doi:10.1002/ags3.12006 - PubMed
  5. Kheir MM, Tan TL, Kheir M, Maltenfort MG, Chen AF. Postoperative blood glucose levels predict infection after total joint arthroplasty. J Bone Joint Surg Am. 2018;100:100-1431. - PubMed
  6. Maradit Kremers H, Lewallen LW, Mabry TM, Berry DJ, Berbari EF, Osmon DR. Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty. J Arthroplasty. 2015;30:439-443. - PubMed
  7. Mraovic B, Suh D, Jacovides C, Parvizi J. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol. 2011;5:5-8. - PubMed
  8. Cornell CN. Assessment of glycemic variability may be the next step in optimizing patients for total joint arthroplasty: commentary on an article by Noam Shohat, MD, et al.: “increased postoperative glucose variability is associated with adverse outcomes following total joint arthroplasty”. J Bone Joint Surg Am. 2018:100. - PubMed
  9. Dortch JD, Eck DL, Ladlie B, TerKonda SP. Perioperative glycemic control in plastic surgery: review and discussion of an institutional protocol. Aesthet Surg J. 2016;36:36-830. - PubMed
  10. Sebranek JJ, Lugli AK, Coursin DB. Glycaemic control in the perioperative period. Br J Anaesth. 2013;111(suppl 1):18-34. - PubMed
  11. Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. 2017;126:126-560. - PubMed
  12. Chrastil J, Anderson MB, Stevens V, Anand R, Peters CL, Pelt CE. Is hemoglobin A1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty? J Arthroplasty. 2015;30:1197-1202. - PubMed
  13. Reátegui D, Sanchez-Etayo G, Núñez E, et al. Perioperative hyperglycaemia and incidence of post-operative complications in patients undergoing total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2015;23:2026-2031. - PubMed
  14. Varady NH, Schwab P-E, Jones T, Collins JE, Fitz W, Chen AF. Optimal timing of glucose measurements after total joint arthroplasty. J Arthroplasty. 2019;34:S152-S158. - PubMed
  15. Gallagher JM, Erich RA, Gattermeyer R, Beam KK. Postoperative hyperglycemia can be safely and effectively controlled in both diabetic and nondiabetic patients with use of a subcutaneous insulin protocol. JBJS Open Access. 2017;2:2. - PubMed
  16. Jones CE, Graham LA, Morris MS, et al. Association between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and readmissions following gastrointestinal surgery. JAMA Surg. 2017;152:1031-1038. - PubMed
  17. Ye Y, Pan B, Gu M, et al. Fluctuation of fasting blood glucose in patients who underwent primary or revision total joint arthroplasty: a retrospective review. J Orthop Surg. 2020;15:15. - PubMed
  18. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:87-82. - PubMed
  19. Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:33-8. - PubMed
  20. Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261:261-103. - PubMed
  21. Akiboye F, Rayman G. Management of hyperglycemia and diabetes in orthopedic surgery. Curr Diab Rep. 2017;17:17. - PubMed
  22. Desai SP, Henry LL, Holmes SD, et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. J Thorac Cardiovasc Surg. 2012;143:143-25. - PubMed
  23. Sudhakaran S, Surani SR. Guidelines for perioperative management of the diabetic patient. Surg Res Pract. 2015;2015:284063. - PubMed
  24. Duncan AE. Hyperglycemia and perioperative glucose management. Curr Pharm Des. 2012;18:6195-6203. - PubMed
  25. Gustafsson UO, Nygren J, Thorell A, et al. Pre-operative carbohydrate loading may be used in type 2 diabetes patients. Acta Anaesthesiol Scand. 2008;52:946-951. - PubMed
  26. Bilku DK, Dennison AR, Hall TC, Metcalfe MS, Garcea G. Role of preoperative carbohydrate loading: a systematic review. Ann R Coll Surg Engl. 2014;96:96-22. - PubMed

Publication Types